Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2024

Oct 28, 2024

30718_dirs_2024-10-28_f5f085f4-9640-42d3-929d-d75c33b0e256.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-10-24

Reporting Person: Klimovsky Judith V (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-24 Common Stock A 1462 Acquired 2142 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-10-24 Stock Option (Right to Buy) $68.37 A 3511 Acquired 2034-10-24 Common Stock (3511) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $73.46 2034-05-01 Common Stock (1610) 1610 Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.